胃肠道出血治疗市场－全球产业规模、份额、趋势、机会和预测，按产品、胃肠道部位、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球胃肠道出血治疗市场规模为5.6244亿美元，预计2030年将以5.88%的复合年增长率增长至7.9234亿美元。全球胃肠道出血治疗市场专注于旨在止血或控制胃肠道（包括食道、胃、小肠、大肠和直肠）出血的医疗干预措施，同时解决潜在病因并预防併发症。

主要市场驱动因素

胃肠道疾病的日益普遍显着地推动了全球胃肠道出血治疗市场的发展。诸如消化性溃疡、胃炎和大肠癌等疾病本身就存在出血风险，需要医疗介入。

主要市场挑战

先进的诊断和治疗设备及手术的高昂成本是全球胃肠道出血治疗市场的重大挑战。这种经济障碍直接限制了市场扩张，限制了创新高效能干预措施的可近性和广泛应用，特别是在医疗预算有限的医疗系统和发展中国家。

主要市场趋势

远距医疗和远距监测在胃肠道出血管理的应用日益广泛，标誌着医疗服务模式的重大变革。这一趋势超越了传统的面对面就诊模式，旨在提供持续的患者追踪和更完善的出院后护理。

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球胃肠道出血治疗市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品分类（闭合装置、内视镜止血装置、其他）
  • 依消化道部位划分（上消化道、下消化道）
  • 依最终使用者（医院/诊所、门诊手术中心、其他）划分
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美胃肠道出血治疗市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲胃肠道出血治疗市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区胃肠道出血治疗市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲胃肠道出血治疗市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲胃肠道出血治疗市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章：全球胃肠道出血治疗市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Boston Scientific Corporation
• Olympus Corporation
• CONMED Corporation
• Ovesco Endoscopy AG
• Erbe Elektromedizin GmbH
• Steris Plc
• US Medical Innovations, LLC
• Pfizer Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Gastrointestinal Bleeding Treatment Market, valued at USD 562.44 Million in 2024, is projected to experience a CAGR of 5.88% to reach USD 792.34 Million by 2030. The Global Gastrointestinal Bleeding Treatment Market focuses on medical interventions designed to halt or manage blood loss originating within the gastrointestinal tract, encompassing the esophagus, stomach, small intestine, large intestine, and rectum, alongside addressing underlying causes and preventing complications.

Key Market Drivers

The increasing prevalence of gastrointestinal disorders significantly drives the Global Gastrointestinal Bleeding Treatment Market. Conditions such as peptic ulcers, gastritis, and colorectal cancer inherently carry a risk of bleeding, necessitating medical intervention. As the global burden of these diseases grows, the demand for effective diagnostic and therapeutic solutions for gastrointestinal bleeding escalates.

Key Market Challenges

The substantial cost associated with advanced diagnostic and therapeutic devices and procedures presents a significant challenging factor within the Global Gastrointestinal Bleeding Treatment Market. This financial impediment directly restrains market expansion by limiting the accessibility and widespread adoption of innovative, highly effective interventions, particularly in healthcare systems with constrained budgets and in developing nations. The high initial capital expenditure required for sophisticated endoscopes, specialized hemostatic instruments, and associated processing units often exceeds the financial capacity of numerous healthcare providers, hindering their ability to invest in these critical technologies.

Key Market Trends

The expansion of telehealth and remote monitoring in gastrointestinal bleeding management represents a significant evolution in healthcare delivery. This trend moves beyond traditional in-person visits to offer continuous patient oversight and enhanced post-discharge care. Telehealth platforms facilitate virtual consultations and enable remote patient monitoring through digital health tools, which supports timely interventions and improves patient engagement by providing convenience and accessibility, especially for individuals in remote areas or those facing mobility challenges.

Key Market Players

• Boston Scientific Corporation
• Olympus Corporation
• CONMED Corporation
• Ovesco Endoscopy AG
• Erbe Elektromedizin GmbH
• Steris Plc
• US Medical Innovations, LLC
• Pfizer Inc.

Report Scope:

In this report, the Global Gastrointestinal Bleeding Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Gastrointestinal Bleeding Treatment Market, By Product:

• Closure Devices
• Endoscopic Hemostatic Devices
• Others

Gastrointestinal Bleeding Treatment Market, By GI Tract Division:

• Upper GI Tract
• Lower GI Tract

Gastrointestinal Bleeding Treatment Market, By End Users:

• Hospital/Clinics
• Ambulatory Surgical Centres
• Others

Gastrointestinal Bleeding Treatment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Gastrointestinal Bleeding Treatment Market.

Available Customizations:

Global Gastrointestinal Bleeding Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Gastrointestinal Bleeding Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Closure Devices, Endoscopic Hemostatic Devices, Others)
  • 5.2.2. By GI Tract Division (Upper GI Tract, Lower GI Tract)
  • 5.2.3. By End Users (Hospital/Clinics, Ambulatory Surgical Centres, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Gastrointestinal Bleeding Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By GI Tract Division
  • 6.2.3. By End Users
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Gastrointestinal Bleeding Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By GI Tract Division
      • 6.3.1.2.3. By End Users
  • 6.3.2. Canada Gastrointestinal Bleeding Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By GI Tract Division
      • 6.3.2.2.3. By End Users
  • 6.3.3. Mexico Gastrointestinal Bleeding Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By GI Tract Division
      • 6.3.3.2.3. By End Users

7. Europe Gastrointestinal Bleeding Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By GI Tract Division
  • 7.2.3. By End Users
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Gastrointestinal Bleeding Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By GI Tract Division
      • 7.3.1.2.3. By End Users
  • 7.3.2. France Gastrointestinal Bleeding Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By GI Tract Division
      • 7.3.2.2.3. By End Users
  • 7.3.3. United Kingdom Gastrointestinal Bleeding Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By GI Tract Division
      • 7.3.3.2.3. By End Users
  • 7.3.4. Italy Gastrointestinal Bleeding Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By GI Tract Division
      • 7.3.4.2.3. By End Users
  • 7.3.5. Spain Gastrointestinal Bleeding Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By GI Tract Division
      • 7.3.5.2.3. By End Users

8. Asia Pacific Gastrointestinal Bleeding Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By GI Tract Division
  • 8.2.3. By End Users
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Gastrointestinal Bleeding Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By GI Tract Division
      • 8.3.1.2.3. By End Users
  • 8.3.2. India Gastrointestinal Bleeding Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By GI Tract Division
      • 8.3.2.2.3. By End Users
  • 8.3.3. Japan Gastrointestinal Bleeding Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By GI Tract Division
      • 8.3.3.2.3. By End Users
  • 8.3.4. South Korea Gastrointestinal Bleeding Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By GI Tract Division
      • 8.3.4.2.3. By End Users
  • 8.3.5. Australia Gastrointestinal Bleeding Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By GI Tract Division
      • 8.3.5.2.3. By End Users

9. Middle East & Africa Gastrointestinal Bleeding Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By GI Tract Division
  • 9.2.3. By End Users
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Gastrointestinal Bleeding Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By GI Tract Division
      • 9.3.1.2.3. By End Users
  • 9.3.2. UAE Gastrointestinal Bleeding Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By GI Tract Division
      • 9.3.2.2.3. By End Users
  • 9.3.3. South Africa Gastrointestinal Bleeding Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By GI Tract Division
      • 9.3.3.2.3. By End Users

10. South America Gastrointestinal Bleeding Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By GI Tract Division
  • 10.2.3. By End Users
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Gastrointestinal Bleeding Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By GI Tract Division
      • 10.3.1.2.3. By End Users
  • 10.3.2. Colombia Gastrointestinal Bleeding Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By GI Tract Division
      • 10.3.2.2.3. By End Users
  • 10.3.3. Argentina Gastrointestinal Bleeding Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By GI Tract Division
      • 10.3.3.2.3. By End Users

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Gastrointestinal Bleeding Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Boston Scientific Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Olympus Corporation
• 15.3. CONMED Corporation
• 15.4. Ovesco Endoscopy AG
• 15.5. Erbe Elektromedizin GmbH
• 15.6. Steris Plc
• 15.7. US Medical Innovations, LLC
• 15.8. Pfizer Inc.

16. Strategic Recommendations

17. About Us & Disclaimer